Brian Piper - Net Worth and Insider Trading
Brian Piper Net Worth
The estimated net worth of Brian Piper is at least $0 dollars as of 2024-12-29. Brian Piper is the CFO of Prelude Therapeutics Inc and owns about 0 shares of Prelude Therapeutics Inc (PRLD) stock worth over $0. Details can be seen in Brian Piper's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Brian Piper has not made any transactions after 2021-08-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Brian Piper
Brian Piper Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Brian Piper owns 2 companies in total, including Prelude Therapeutics Inc (PRLD) , and Aevi Genomic Medicine Inc (GNMX) .
Click here to see the complete history of Brian Piper’s form 4 insider trades.
Insider Ownership Summary of Brian Piper
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PRLD | Prelude Therapeutics Inc | 2021-08-25 | Chief Financial Officer |
| GNMX | Aevi Genomic Medicine Inc | 2018-06-14 | CFO & Corporate Secretary |
Brian Piper Latest Holdings Summary
Brian Piper currently owns a total of 1 stock. Brian Piper owns 0 shares of Prelude Therapeutics Inc (PRLD) as of August 25, 2021, with a value of $0.
Latest Holdings of Brian Piper
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PRLD | Prelude Therapeutics Inc | 2021-08-25 | 0 | 1.34 | 0 |
Holding Weightings of Brian Piper
Brian Piper Form 4 Trading Tracker
According to the SEC Form 4 filings, Brian Piper has made a total of 2 transactions in Prelude Therapeutics Inc (PRLD) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Prelude Therapeutics Inc is the sale of 8,333 shares on August 25, 2021, which brought Brian Piper around $277,822.
Insider Trading History of Brian Piper
- 1
Brian Piper Trading Performance
Brian Piper Ownership Network
Brian Piper Owned Company Details
What does Prelude Therapeutics Inc do?
Who are the key executives at Prelude Therapeutics Inc?
Brian Piper is the Chief Financial Officer of Prelude Therapeutics Inc. Other key executives at Prelude Therapeutics Inc include EVP & Head of Chemistry Andrew Combs , director & President & CEO Krishna Vaddi , and Chief Legal Counsel & Corp Sec. Bryant David Lim .
Prelude Therapeutics Inc (PRLD) Insider Trades Summary
Over the past 18 months, Brian Piper made no insider transaction in Prelude Therapeutics Inc (PRLD). Other recent insider transactions involving Prelude Therapeutics Inc (PRLD) include a net purchase of 106,888 shares made by Krishna Vaddi , a net purchase of 63,075 shares made by Andrew Combs , and a net purchase of 25,000 shares made by Bryant David Lim .
In summary, during the past 3 months, insiders sold 0 shares of Prelude Therapeutics Inc (PRLD) in total and bought 194,963 shares, with a net purchase of 194,963 shares. During the past 18 months, 0 shares of Prelude Therapeutics Inc (PRLD) were sold and 194,963 shares were bought by its insiders, resulting in a net purchase of 194,963 shares.
Prelude Therapeutics Inc (PRLD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Prelude Therapeutics Inc Insider Transactions
Brian Piper Mailing Address
Above is the net worth, insider trading, and ownership report for Brian Piper. You might contact Brian Piper via mailing address: C/o Medgenics, Inc., 435 Devon Park Drive, Bldg. 700, Wayne Pa 19087.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
